LMAN2L and chronic obstructive pulmonary disease: LMAN2L’s pivotal role in ER quality control enables prediction of chemotherapy sensitivity through ER stress biomarkers, while AAV vector-based gene supplementation shows promise in rectifying proteostatic imbalance, as preliminarily validated in COPD models.